Dr. Reddy’s Laboratories Ltd (RDY) has released an update.
Dr. Reddy’s Laboratories Ltd. has announced the completion of a routine USFDA GMP inspection at their manufacturing facilities in Duvvada, Visakhapatnam, which resulted in receiving two observations. The company has committed to addressing these observations within the required timeline. This regulatory update is crucial for investors tracking the company’s compliance and operational progress.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.